Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB

被引:38
作者
Dai, CH
Chung, IJ
Krantz, SB
机构
[1] Vanderbilt Univ, Sch Med, Dept Med, Div Hematol Oncol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
[3] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA
关键词
D O I
10.1016/j.exphem.2004.10.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The aim of this study was to explore the mechanism by which increased erythropoiesis occurs in polycythemia vera (PV). Methods. CD34(+) and erythroid colony-forming cells (ECFC) were purified from normal or PV peripheral blood and then incubated in the presence of erythropoietin (EPO) to generate erythroid progenitor cells. Measurement of proliferation by Ki-67 staining, TUNEL assays to measure apoptosis, and Western blots for detection of Akt/PKB and glycogen synthase kinase 3 (GSK3) phosphorylation were performed in both normal and PV erythroid progenitors. Results. Polycythemia vera erythroid progenitor cells generated 60% more cells compared to normal cells in liquid medium cell cultures. TUNEL assays revealed no difference between PV and normal erythroid progenitors, but Ki-67 staining for cell proliferation showed many more positive cells in the PV samples. A marked increase of phosphorylation of Akt/PKB occurred in the day-8 erythroid progenitors of 415 PV patients, compared to normal cells, after incubation with either stem cell factor (SCF) or EPO. PV cells also had much greater glycogen synthase kinase 3 (GSK3) alpha,beta phosphorylation compared to normal cells after incubation with SCF or EPO. These results are parallel to the cellular hypersensitivity of PV cells to SCF and EPO previously reported. Conclusions. Increased erythropoiesis in PV is associated with increased cellular proliferation and increased phosphorylation of Akt/PKB and GSK3. This study provides additional insight into the pathogenesis of PV and the regulation of normal erythropoiesis, even though a specific molecular defect of the disease is still not apparent. (C) 2005 International Society for Experimental Hematology. Published by Elsevier Inc.
引用
收藏
页码:152 / 158
页数:7
相关论文
共 51 条
  • [1] POLYCYTHEMIA-VERA - FURTHER INVITRO STUDIES OF HEMATOPOIETIC REGULATION
    ADAMSON, JW
    SINGER, JW
    CATALANO, P
    MURPHY, S
    LIN, N
    STEINMANN, L
    ERNST, C
    FIALKOW, PJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (06) : 1363 - 1368
  • [2] The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera
    Asimakopoulos, FA
    Hinshelwood, S
    Gilbert, JGR
    Delibrias, CC
    Gottgens, B
    Fearon, DT
    Green, AR
    [J]. ONCOGENE, 1997, 14 (10) : 1215 - 1222
  • [3] Ten years of protein kinase B signalling: a hard Akt to follow
    Brazil, DP
    Hemmings, BA
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (11) : 657 - 664
  • [4] CASADEVALL N, 1982, BLOOD, V59, P447
  • [5] CORREA PN, 1994, BLOOD, V83, P99
  • [6] Polycythemia vera .5. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: A possible defect of phosphatase activity in polycythemia vera
    Dai, CH
    Krantz, SB
    Sawyer, ST
    [J]. BLOOD, 1997, 89 (10) : 3574 - 3581
  • [7] Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon γ to produce erythroid cell apoptosis
    Dai, CH
    Price, JO
    Brunner, T
    Krantz, SB
    [J]. BLOOD, 1998, 91 (04) : 1235 - 1242
  • [8] POLYCYTHEMIA-VERA .3. BURST-FORMING UNITS-ERYTHROID (BFU-E) RESPONSE TO STEM-CELL FACTOR AND C-KIT RECEPTOR EXPRESSION
    DAI, CH
    KRANTZ, SB
    GREEN, WF
    GILBERT, HS
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (01) : 12 - 21
  • [9] POLYCYTHEMIA-VERA BLOOD BURST-FORMING UNITS-ERYTHROID ARE HYPERSENSITIVE TO INTERLEUKIN-3
    DAI, CH
    KRANTZ, SB
    MEANS, RT
    HORN, ST
    GILBERT, HS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) : 391 - 396
  • [10] DAI CH, 1992, BLOOD, V80, P891